nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CYP3A4—Temozolomide—brain cancer	0.254	0.486	CbGbCtD
Maraviroc—CYP3A4—Lomustine—brain cancer	0.216	0.414	CbGbCtD
Maraviroc—CYP3A4—Etoposide—brain cancer	0.0523	0.1	CbGbCtD
Maraviroc—CCR5—spinal cord—brain cancer	0.00299	0.226	CbGeAlD
Maraviroc—CCR5—endocrine gland—brain cancer	0.00269	0.204	CbGeAlD
Maraviroc—CCR5—head—brain cancer	0.00265	0.201	CbGeAlD
Maraviroc—CCR5—GPCRs, Other—SMO—brain cancer	0.00265	0.0602	CbGpPWpGaD
Maraviroc—CCR5—central nervous system—brain cancer	0.00242	0.184	CbGeAlD
Maraviroc—CCR5—TCR Signaling Pathway—VAV1—brain cancer	0.00203	0.0463	CbGpPWpGaD
Maraviroc—CCR5—brain—brain cancer	0.00192	0.146	CbGeAlD
Maraviroc—CCR5—GPCR ligand binding—PTCH2—brain cancer	0.00154	0.0349	CbGpPWpGaD
Maraviroc—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.00147	0.0035	CcSEcCtD
Maraviroc—Hallucination—Procarbazine—brain cancer	0.00145	0.00347	CcSEcCtD
Maraviroc—Inflammation—Etoposide—brain cancer	0.00145	0.00346	CcSEcCtD
Maraviroc—Vascular purpura—Temozolomide—brain cancer	0.00143	0.0034	CcSEcCtD
Maraviroc—Deafness—Temozolomide—brain cancer	0.00143	0.0034	CcSEcCtD
Maraviroc—Decreased appetite—Lomustine—brain cancer	0.00142	0.00339	CcSEcCtD
Maraviroc—Hepatic failure—Temozolomide—brain cancer	0.00142	0.00339	CcSEcCtD
Maraviroc—Amnesia—Carmustine—brain cancer	0.00141	0.00335	CcSEcCtD
Maraviroc—Nasal congestion—Temozolomide—brain cancer	0.0014	0.00334	CcSEcCtD
Maraviroc—CCR5—IL12-mediated signaling events—RELA—brain cancer	0.0014	0.0318	CbGpPWpGaD
Maraviroc—Pancreatitis—Hydroxyurea—brain cancer	0.00139	0.0033	CcSEcCtD
Maraviroc—Amnesia—Temozolomide—brain cancer	0.00136	0.00324	CcSEcCtD
Maraviroc—Dermatitis exfoliative—Temozolomide—brain cancer	0.00135	0.00323	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—OR14C36—brain cancer	0.00135	0.0306	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—OR4C12—brain cancer	0.00135	0.0306	CbGpPWpGaD
Maraviroc—Pancytopenia—Hydroxyurea—brain cancer	0.00134	0.0032	CcSEcCtD
Maraviroc—Purpura—Temozolomide—brain cancer	0.00133	0.00316	CcSEcCtD
Maraviroc—Neutropenia—Hydroxyurea—brain cancer	0.00132	0.00315	CcSEcCtD
Maraviroc—Body temperature increased—Lomustine—brain cancer	0.00129	0.00308	CcSEcCtD
Maraviroc—Alopecia—Procarbazine—brain cancer	0.00129	0.00308	CcSEcCtD
Maraviroc—Infestation—Hydroxyurea—brain cancer	0.00126	0.003	CcSEcCtD
Maraviroc—Infestation NOS—Hydroxyurea—brain cancer	0.00126	0.003	CcSEcCtD
Maraviroc—CCR5—IL12-mediated signaling events—IL2—brain cancer	0.00126	0.0286	CbGpPWpGaD
Maraviroc—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00124	0.00294	CcSEcCtD
Maraviroc—Stomatitis—Hydroxyurea—brain cancer	0.00123	0.00293	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—OR14C36—brain cancer	0.00122	0.0278	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—OR4C12—brain cancer	0.00122	0.0278	CbGpPWpGaD
Maraviroc—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00121	0.0275	CbGpPWpGaD
Maraviroc—Tremor—Procarbazine—brain cancer	0.00119	0.00284	CcSEcCtD
Maraviroc—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00119	0.00284	CcSEcCtD
Maraviroc—Anaemia—Procarbazine—brain cancer	0.00118	0.0028	CcSEcCtD
Maraviroc—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.00118	0.0028	CcSEcCtD
Maraviroc—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00116	0.0265	CbGpPWpGaD
Maraviroc—Breast disorder—Temozolomide—brain cancer	0.00115	0.00275	CcSEcCtD
Maraviroc—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00115	0.00274	CcSEcCtD
Maraviroc—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00115	0.00274	CcSEcCtD
Maraviroc—Syncope—Procarbazine—brain cancer	0.00114	0.00272	CcSEcCtD
Maraviroc—Leukopenia—Procarbazine—brain cancer	0.00114	0.00271	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00113	0.00268	CcSEcCtD
Maraviroc—Hallucination—Hydroxyurea—brain cancer	0.00113	0.00268	CcSEcCtD
Maraviroc—Loss of consciousness—Procarbazine—brain cancer	0.00112	0.00266	CcSEcCtD
Maraviroc—Abdominal distension—Temozolomide—brain cancer	0.00111	0.00265	CcSEcCtD
Maraviroc—Cough—Procarbazine—brain cancer	0.00111	0.00265	CcSEcCtD
Maraviroc—Convulsion—Procarbazine—brain cancer	0.0011	0.00263	CcSEcCtD
Maraviroc—Pancytopenia—Carmustine—brain cancer	0.00109	0.00259	CcSEcCtD
Maraviroc—Myalgia—Procarbazine—brain cancer	0.00108	0.00258	CcSEcCtD
Maraviroc—Anxiety—Procarbazine—brain cancer	0.00108	0.00257	CcSEcCtD
Maraviroc—Neutropenia—Carmustine—brain cancer	0.00107	0.00255	CcSEcCtD
Maraviroc—Bronchitis—Temozolomide—brain cancer	0.00106	0.00253	CcSEcCtD
Maraviroc—CCR5—IL12-mediated signaling events—STAT3—brain cancer	0.00106	0.0241	CbGpPWpGaD
Maraviroc—Pancytopenia—Temozolomide—brain cancer	0.00105	0.0025	CcSEcCtD
Maraviroc—Vomiting—Lomustine—brain cancer	0.00104	0.00248	CcSEcCtD
Maraviroc—Oedema—Procarbazine—brain cancer	0.00104	0.00247	CcSEcCtD
Maraviroc—Neutropenia—Temozolomide—brain cancer	0.00103	0.00246	CcSEcCtD
Maraviroc—Infection—Procarbazine—brain cancer	0.00103	0.00246	CcSEcCtD
Maraviroc—Angiopathy—Hydroxyurea—brain cancer	0.00103	0.00245	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Temozolomide—brain cancer	0.00103	0.00245	CcSEcCtD
Maraviroc—Pneumonia—Carmustine—brain cancer	0.00103	0.00244	CcSEcCtD
Maraviroc—Shock—Procarbazine—brain cancer	0.00102	0.00243	CcSEcCtD
Maraviroc—Depression—Carmustine—brain cancer	0.00102	0.00242	CcSEcCtD
Maraviroc—CCR5—TCR Signaling Pathway—RELA—brain cancer	0.00101	0.023	CbGpPWpGaD
Maraviroc—Renal failure—Carmustine—brain cancer	0.001	0.00239	CcSEcCtD
Maraviroc—Alopecia—Hydroxyurea—brain cancer	0.001	0.00238	CcSEcCtD
Maraviroc—Neuropathy peripheral—Carmustine—brain cancer	0.000999	0.00238	CcSEcCtD
Maraviroc—Stomatitis—Carmustine—brain cancer	0.000993	0.00237	CcSEcCtD
Maraviroc—Pneumonia—Temozolomide—brain cancer	0.000991	0.00236	CcSEcCtD
Maraviroc—Anorexia—Procarbazine—brain cancer	0.00099	0.00236	CcSEcCtD
Maraviroc—Erythema—Hydroxyurea—brain cancer	0.000985	0.00235	CcSEcCtD
Maraviroc—Infestation—Temozolomide—brain cancer	0.000985	0.00235	CcSEcCtD
Maraviroc—Infestation NOS—Temozolomide—brain cancer	0.000985	0.00235	CcSEcCtD
Maraviroc—Depression—Temozolomide—brain cancer	0.000982	0.00234	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000976	0.00233	CcSEcCtD
Maraviroc—Nausea—Lomustine—brain cancer	0.000972	0.00232	CcSEcCtD
Maraviroc—Neuropathy peripheral—Temozolomide—brain cancer	0.000965	0.0023	CcSEcCtD
Maraviroc—Stomatitis—Temozolomide—brain cancer	0.00096	0.00229	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000946	0.00225	CcSEcCtD
Maraviroc—Insomnia—Procarbazine—brain cancer	0.00094	0.00224	CcSEcCtD
Maraviroc—Paraesthesia—Procarbazine—brain cancer	0.000933	0.00222	CcSEcCtD
Maraviroc—Hepatobiliary disease—Temozolomide—brain cancer	0.000931	0.00222	CcSEcCtD
Maraviroc—Sinusitis—Temozolomide—brain cancer	0.000924	0.0022	CcSEcCtD
Maraviroc—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000921	0.00219	CcSEcCtD
Maraviroc—Anaemia—Hydroxyurea—brain cancer	0.000911	0.00217	CcSEcCtD
Maraviroc—Hallucination—Carmustine—brain cancer	0.00091	0.00217	CcSEcCtD
Maraviroc—Decreased appetite—Procarbazine—brain cancer	0.000903	0.00215	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Etoposide—brain cancer	0.000902	0.00215	CcSEcCtD
Maraviroc—Connective tissue disorder—Carmustine—brain cancer	0.000899	0.00214	CcSEcCtD
Maraviroc—Fatigue—Procarbazine—brain cancer	0.000896	0.00213	CcSEcCtD
Maraviroc—Constipation—Procarbazine—brain cancer	0.000888	0.00212	CcSEcCtD
Maraviroc—Pain—Procarbazine—brain cancer	0.000888	0.00212	CcSEcCtD
Maraviroc—Leukopenia—Hydroxyurea—brain cancer	0.000882	0.0021	CcSEcCtD
Maraviroc—Hallucination—Temozolomide—brain cancer	0.00088	0.0021	CcSEcCtD
Maraviroc—Pharyngitis—Temozolomide—brain cancer	0.000877	0.00209	CcSEcCtD
Maraviroc—CCR5—Disease—DTX2—brain cancer	0.000877	0.02	CbGpPWpGaD
Maraviroc—Urinary tract disorder—Temozolomide—brain cancer	0.000873	0.00208	CcSEcCtD
Maraviroc—Bronchospasm—Etoposide—brain cancer	0.000869	0.00207	CcSEcCtD
Maraviroc—Connective tissue disorder—Temozolomide—brain cancer	0.000869	0.00207	CcSEcCtD
Maraviroc—Urethral disorder—Temozolomide—brain cancer	0.000867	0.00206	CcSEcCtD
Maraviroc—Eye disorder—Carmustine—brain cancer	0.000855	0.00204	CcSEcCtD
Maraviroc—Convulsion—Hydroxyurea—brain cancer	0.000854	0.00203	CcSEcCtD
Maraviroc—Gastrointestinal pain—Procarbazine—brain cancer	0.00085	0.00202	CcSEcCtD
Maraviroc—Pancytopenia—Etoposide—brain cancer	0.000839	0.002	CcSEcCtD
Maraviroc—Erythema multiforme—Temozolomide—brain cancer	0.000836	0.00199	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000833	0.00198	CcSEcCtD
Maraviroc—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000831	0.0189	CbGpPWpGaD
Maraviroc—Discomfort—Hydroxyurea—brain cancer	0.000829	0.00197	CcSEcCtD
Maraviroc—Neutropenia—Etoposide—brain cancer	0.000826	0.00197	CcSEcCtD
Maraviroc—Eye disorder—Temozolomide—brain cancer	0.000826	0.00197	CcSEcCtD
Maraviroc—Body temperature increased—Procarbazine—brain cancer	0.000821	0.00196	CcSEcCtD
Maraviroc—Abdominal pain—Procarbazine—brain cancer	0.000821	0.00196	CcSEcCtD
Maraviroc—Cardiac disorder—Temozolomide—brain cancer	0.00082	0.00195	CcSEcCtD
Maraviroc—Alopecia—Carmustine—brain cancer	0.000808	0.00193	CcSEcCtD
Maraviroc—Oedema—Hydroxyurea—brain cancer	0.000804	0.00192	CcSEcCtD
Maraviroc—Angiopathy—Temozolomide—brain cancer	0.000802	0.00191	CcSEcCtD
Maraviroc—Mental disorder—Carmustine—brain cancer	0.000801	0.00191	CcSEcCtD
Maraviroc—Infection—Hydroxyurea—brain cancer	0.000799	0.0019	CcSEcCtD
Maraviroc—Mediastinal disorder—Temozolomide—brain cancer	0.000797	0.0019	CcSEcCtD
Maraviroc—Erythema—Carmustine—brain cancer	0.000796	0.0019	CcSEcCtD
Maraviroc—Malnutrition—Carmustine—brain cancer	0.000796	0.0019	CcSEcCtD
Maraviroc—Pneumonia—Etoposide—brain cancer	0.000793	0.00189	CcSEcCtD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000791	0.018	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—SHH—brain cancer	0.000791	0.018	CbGpPWpGaD
Maraviroc—Nervous system disorder—Hydroxyurea—brain cancer	0.000788	0.00188	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—PTCH2—brain cancer	0.000788	0.0179	CbGpPWpGaD
Maraviroc—Infestation NOS—Etoposide—brain cancer	0.000788	0.00188	CcSEcCtD
Maraviroc—Infestation—Etoposide—brain cancer	0.000788	0.00188	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000781	0.00186	CcSEcCtD
Maraviroc—Alopecia—Temozolomide—brain cancer	0.000781	0.00186	CcSEcCtD
Maraviroc—Skin disorder—Hydroxyurea—brain cancer	0.000781	0.00186	CcSEcCtD
Maraviroc—Acute coronary syndrome—Etoposide—brain cancer	0.000777	0.00185	CcSEcCtD
Maraviroc—Renal failure—Etoposide—brain cancer	0.000775	0.00185	CcSEcCtD
Maraviroc—Mental disorder—Temozolomide—brain cancer	0.000775	0.00184	CcSEcCtD
Maraviroc—Neuropathy peripheral—Etoposide—brain cancer	0.000772	0.00184	CcSEcCtD
Maraviroc—Myocardial infarction—Etoposide—brain cancer	0.000772	0.00184	CcSEcCtD
Maraviroc—Malnutrition—Temozolomide—brain cancer	0.00077	0.00183	CcSEcCtD
Maraviroc—Erythema—Temozolomide—brain cancer	0.00077	0.00183	CcSEcCtD
Maraviroc—Stomatitis—Etoposide—brain cancer	0.000768	0.00183	CcSEcCtD
Maraviroc—Jaundice—Etoposide—brain cancer	0.000768	0.00183	CcSEcCtD
Maraviroc—Anorexia—Hydroxyurea—brain cancer	0.000766	0.00183	CcSEcCtD
Maraviroc—Hypersensitivity—Procarbazine—brain cancer	0.000765	0.00182	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—PTCH1—brain cancer	0.00075	0.0171	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—SMO—brain cancer	0.00075	0.0171	CbGpPWpGaD
Maraviroc—Tremor—Carmustine—brain cancer	0.000746	0.00178	CcSEcCtD
Maraviroc—Asthenia—Procarbazine—brain cancer	0.000745	0.00178	CcSEcCtD
Maraviroc—Hepatobiliary disease—Etoposide—brain cancer	0.000745	0.00178	CcSEcCtD
Maraviroc—Anaemia—Carmustine—brain cancer	0.000736	0.00175	CcSEcCtD
Maraviroc—Agranulocytosis—Etoposide—brain cancer	0.000735	0.00175	CcSEcCtD
Maraviroc—Pruritus—Procarbazine—brain cancer	0.000735	0.00175	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—OR14C36—brain cancer	0.000723	0.0164	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—OR4C12—brain cancer	0.000723	0.0164	CbGpPWpGaD
Maraviroc—Tremor—Temozolomide—brain cancer	0.000721	0.00172	CcSEcCtD
Maraviroc—Leukopenia—Carmustine—brain cancer	0.000713	0.0017	CcSEcCtD
Maraviroc—Anaemia—Temozolomide—brain cancer	0.000711	0.00169	CcSEcCtD
Maraviroc—Diarrhoea—Procarbazine—brain cancer	0.000711	0.00169	CcSEcCtD
Maraviroc—Decreased appetite—Hydroxyurea—brain cancer	0.000699	0.00166	CcSEcCtD
Maraviroc—Urinary tract disorder—Etoposide—brain cancer	0.000699	0.00166	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000694	0.00165	CcSEcCtD
Maraviroc—Urethral disorder—Etoposide—brain cancer	0.000693	0.00165	CcSEcCtD
Maraviroc—Fatigue—Hydroxyurea—brain cancer	0.000693	0.00165	CcSEcCtD
Maraviroc—Convulsion—Carmustine—brain cancer	0.00069	0.00164	CcSEcCtD
Maraviroc—Leukopenia—Temozolomide—brain cancer	0.000689	0.00164	CcSEcCtD
Maraviroc—Constipation—Hydroxyurea—brain cancer	0.000688	0.00164	CcSEcCtD
Maraviroc—Pain—Hydroxyurea—brain cancer	0.000688	0.00164	CcSEcCtD
Maraviroc—Dizziness—Procarbazine—brain cancer	0.000687	0.00164	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—ABR—brain cancer	0.000681	0.0155	CbGpPWpGaD
Maraviroc—Myalgia—Carmustine—brain cancer	0.000678	0.00161	CcSEcCtD
Maraviroc—Anxiety—Carmustine—brain cancer	0.000676	0.00161	CcSEcCtD
Maraviroc—Cough—Temozolomide—brain cancer	0.000672	0.0016	CcSEcCtD
Maraviroc—Erythema multiforme—Etoposide—brain cancer	0.000669	0.00159	CcSEcCtD
Maraviroc—Convulsion—Temozolomide—brain cancer	0.000667	0.00159	CcSEcCtD
Maraviroc—Eye disorder—Etoposide—brain cancer	0.000661	0.00157	CcSEcCtD
Maraviroc—Vomiting—Procarbazine—brain cancer	0.000661	0.00157	CcSEcCtD
Maraviroc—Cardiac disorder—Etoposide—brain cancer	0.000657	0.00156	CcSEcCtD
Maraviroc—Myalgia—Temozolomide—brain cancer	0.000655	0.00156	CcSEcCtD
Maraviroc—Rash—Procarbazine—brain cancer	0.000655	0.00156	CcSEcCtD
Maraviroc—Dermatitis—Procarbazine—brain cancer	0.000654	0.00156	CcSEcCtD
Maraviroc—Anxiety—Temozolomide—brain cancer	0.000653	0.00156	CcSEcCtD
Maraviroc—Headache—Procarbazine—brain cancer	0.000651	0.00155	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000651	0.00155	CcSEcCtD
Maraviroc—Oedema—Carmustine—brain cancer	0.00065	0.00155	CcSEcCtD
Maraviroc—Discomfort—Temozolomide—brain cancer	0.000647	0.00154	CcSEcCtD
Maraviroc—Infection—Carmustine—brain cancer	0.000646	0.00154	CcSEcCtD
Maraviroc—CCR5—Disease—HES5—brain cancer	0.000644	0.0147	CbGpPWpGaD
Maraviroc—Angiopathy—Etoposide—brain cancer	0.000642	0.00153	CcSEcCtD
Maraviroc—Mediastinal disorder—Etoposide—brain cancer	0.000638	0.00152	CcSEcCtD
Maraviroc—Body temperature increased—Hydroxyurea—brain cancer	0.000636	0.00151	CcSEcCtD
Maraviroc—Oedema—Temozolomide—brain cancer	0.000628	0.0015	CcSEcCtD
Maraviroc—Alopecia—Etoposide—brain cancer	0.000625	0.00149	CcSEcCtD
Maraviroc—Infection—Temozolomide—brain cancer	0.000624	0.00149	CcSEcCtD
Maraviroc—Anorexia—Carmustine—brain cancer	0.00062	0.00148	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—ABR—brain cancer	0.000618	0.0141	CbGpPWpGaD
Maraviroc—Nausea—Procarbazine—brain cancer	0.000617	0.00147	CcSEcCtD
Maraviroc—Nervous system disorder—Temozolomide—brain cancer	0.000616	0.00147	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—DTX2—brain cancer	0.000614	0.014	CbGpPWpGaD
Maraviroc—Skin disorder—Temozolomide—brain cancer	0.00061	0.00145	CcSEcCtD
Maraviroc—Anorexia—Temozolomide—brain cancer	0.000599	0.00143	CcSEcCtD
Maraviroc—Hypersensitivity—Hydroxyurea—brain cancer	0.000592	0.00141	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Carmustine—brain cancer	0.000592	0.00141	CcSEcCtD
Maraviroc—Insomnia—Carmustine—brain cancer	0.000588	0.0014	CcSEcCtD
Maraviroc—Paraesthesia—Carmustine—brain cancer	0.000584	0.00139	CcSEcCtD
Maraviroc—Asthenia—Hydroxyurea—brain cancer	0.000577	0.00137	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000572	0.00136	CcSEcCtD
Maraviroc—Anaemia—Etoposide—brain cancer	0.000569	0.00136	CcSEcCtD
Maraviroc—Insomnia—Temozolomide—brain cancer	0.000568	0.00135	CcSEcCtD
Maraviroc—Decreased appetite—Carmustine—brain cancer	0.000565	0.00135	CcSEcCtD
Maraviroc—Paraesthesia—Temozolomide—brain cancer	0.000564	0.00134	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Carmustine—brain cancer	0.000561	0.00134	CcSEcCtD
Maraviroc—Pain—Carmustine—brain cancer	0.000556	0.00132	CcSEcCtD
Maraviroc—Constipation—Carmustine—brain cancer	0.000556	0.00132	CcSEcCtD
Maraviroc—Leukopenia—Etoposide—brain cancer	0.000551	0.00131	CcSEcCtD
Maraviroc—Diarrhoea—Hydroxyurea—brain cancer	0.00055	0.00131	CcSEcCtD
Maraviroc—Decreased appetite—Temozolomide—brain cancer	0.000546	0.0013	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Temozolomide—brain cancer	0.000542	0.00129	CcSEcCtD
Maraviroc—Fatigue—Temozolomide—brain cancer	0.000542	0.00129	CcSEcCtD
Maraviroc—Loss of consciousness—Etoposide—brain cancer	0.000541	0.00129	CcSEcCtD
Maraviroc—Cough—Etoposide—brain cancer	0.000537	0.00128	CcSEcCtD
Maraviroc—Pain—Temozolomide—brain cancer	0.000537	0.00128	CcSEcCtD
Maraviroc—Constipation—Temozolomide—brain cancer	0.000537	0.00128	CcSEcCtD
Maraviroc—Convulsion—Etoposide—brain cancer	0.000534	0.00127	CcSEcCtD
Maraviroc—Dizziness—Hydroxyurea—brain cancer	0.000532	0.00127	CcSEcCtD
Maraviroc—Gastrointestinal pain—Carmustine—brain cancer	0.000531	0.00127	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000521	0.00124	CcSEcCtD
Maraviroc—Discomfort—Etoposide—brain cancer	0.000518	0.00123	CcSEcCtD
Maraviroc—Abdominal pain—Carmustine—brain cancer	0.000514	0.00122	CcSEcCtD
Maraviroc—Body temperature increased—Carmustine—brain cancer	0.000514	0.00122	CcSEcCtD
Maraviroc—Gastrointestinal pain—Temozolomide—brain cancer	0.000514	0.00122	CcSEcCtD
Maraviroc—Vomiting—Hydroxyurea—brain cancer	0.000511	0.00122	CcSEcCtD
Maraviroc—Rash—Hydroxyurea—brain cancer	0.000507	0.00121	CcSEcCtD
Maraviroc—Dermatitis—Hydroxyurea—brain cancer	0.000506	0.00121	CcSEcCtD
Maraviroc—Headache—Hydroxyurea—brain cancer	0.000504	0.0012	CcSEcCtD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000502	0.0114	CbGpPWpGaD
Maraviroc—Infection—Etoposide—brain cancer	0.000499	0.00119	CcSEcCtD
Maraviroc—Body temperature increased—Temozolomide—brain cancer	0.000497	0.00118	CcSEcCtD
Maraviroc—Abdominal pain—Temozolomide—brain cancer	0.000497	0.00118	CcSEcCtD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000496	0.0113	CbGpPWpGaD
Maraviroc—Skin disorder—Etoposide—brain cancer	0.000488	0.00116	CcSEcCtD
Maraviroc—Anorexia—Etoposide—brain cancer	0.000479	0.00114	CcSEcCtD
Maraviroc—Hypersensitivity—Carmustine—brain cancer	0.000479	0.00114	CcSEcCtD
Maraviroc—Nausea—Hydroxyurea—brain cancer	0.000478	0.00114	CcSEcCtD
Maraviroc—Asthenia—Carmustine—brain cancer	0.000466	0.00111	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PTCH2—brain cancer	0.000466	0.0106	CbGpPWpGaD
Maraviroc—Hypersensitivity—Temozolomide—brain cancer	0.000463	0.0011	CcSEcCtD
Maraviroc—Paraesthesia—Etoposide—brain cancer	0.000451	0.00107	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—HES5—brain cancer	0.000451	0.0103	CbGpPWpGaD
Maraviroc—Asthenia—Temozolomide—brain cancer	0.000451	0.00107	CcSEcCtD
Maraviroc—Diarrhoea—Carmustine—brain cancer	0.000445	0.00106	CcSEcCtD
Maraviroc—Pruritus—Temozolomide—brain cancer	0.000444	0.00106	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—STRADA—brain cancer	0.000438	0.00996	CbGpPWpGaD
Maraviroc—Decreased appetite—Etoposide—brain cancer	0.000437	0.00104	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Etoposide—brain cancer	0.000434	0.00103	CcSEcCtD
Maraviroc—Fatigue—Etoposide—brain cancer	0.000433	0.00103	CcSEcCtD
Maraviroc—CCR5—Disease—IDH1—brain cancer	0.000433	0.00986	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—TRPC6—brain cancer	0.000431	0.00981	CbGpPWpGaD
Maraviroc—Dizziness—Carmustine—brain cancer	0.00043	0.00102	CcSEcCtD
Maraviroc—Constipation—Etoposide—brain cancer	0.00043	0.00102	CcSEcCtD
Maraviroc—Pain—Etoposide—brain cancer	0.00043	0.00102	CcSEcCtD
Maraviroc—Diarrhoea—Temozolomide—brain cancer	0.00043	0.00102	CcSEcCtD
Maraviroc—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000427	0.00971	CbGpPWpGaD
Maraviroc—Dizziness—Temozolomide—brain cancer	0.000415	0.000989	CcSEcCtD
Maraviroc—Vomiting—Carmustine—brain cancer	0.000413	0.000984	CcSEcCtD
Maraviroc—Gastrointestinal pain—Etoposide—brain cancer	0.000411	0.000979	CcSEcCtD
Maraviroc—CCR5—Disease—HEY1—brain cancer	0.000411	0.00935	CbGpPWpGaD
Maraviroc—Rash—Carmustine—brain cancer	0.00041	0.000976	CcSEcCtD
Maraviroc—Dermatitis—Carmustine—brain cancer	0.000409	0.000975	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000407	0.00927	CbGpPWpGaD
Maraviroc—Headache—Carmustine—brain cancer	0.000407	0.00097	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—SHH—brain cancer	0.000406	0.00924	CbGpPWpGaD
Maraviroc—CCR5—Disease—DLL1—brain cancer	0.000403	0.00917	CbGpPWpGaD
Maraviroc—Vomiting—Temozolomide—brain cancer	0.000399	0.000951	CcSEcCtD
Maraviroc—Body temperature increased—Etoposide—brain cancer	0.000397	0.000946	CcSEcCtD
Maraviroc—Abdominal pain—Etoposide—brain cancer	0.000397	0.000946	CcSEcCtD
Maraviroc—Rash—Temozolomide—brain cancer	0.000396	0.000943	CcSEcCtD
Maraviroc—Dermatitis—Temozolomide—brain cancer	0.000396	0.000942	CcSEcCtD
Maraviroc—Headache—Temozolomide—brain cancer	0.000393	0.000937	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—TRPC6—brain cancer	0.000392	0.00891	CbGpPWpGaD
Maraviroc—Nausea—Carmustine—brain cancer	0.000386	0.00092	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—PTCH1—brain cancer	0.000385	0.00876	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—SMO—brain cancer	0.000385	0.00876	CbGpPWpGaD
Maraviroc—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000378	0.00861	CbGpPWpGaD
Maraviroc—Nausea—Temozolomide—brain cancer	0.000373	0.000889	CcSEcCtD
Maraviroc—Hypersensitivity—Etoposide—brain cancer	0.00037	0.000882	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ABR—brain cancer	0.000365	0.00831	CbGpPWpGaD
Maraviroc—Asthenia—Etoposide—brain cancer	0.000361	0.000859	CcSEcCtD
Maraviroc—Pruritus—Etoposide—brain cancer	0.000356	0.000847	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—GLI2—brain cancer	0.000353	0.00803	CbGpPWpGaD
Maraviroc—Diarrhoea—Etoposide—brain cancer	0.000344	0.000819	CcSEcCtD
Maraviroc—CCR5—Disease—SHH—brain cancer	0.000343	0.00779	CbGpPWpGaD
Maraviroc—CCR5—Disease—ENO2—brain cancer	0.000343	0.00779	CbGpPWpGaD
Maraviroc—Dizziness—Etoposide—brain cancer	0.000332	0.000792	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—GLI1—brain cancer	0.000332	0.00755	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—VAV1—brain cancer	0.000323	0.00735	CbGpPWpGaD
Maraviroc—Vomiting—Etoposide—brain cancer	0.00032	0.000761	CcSEcCtD
Maraviroc—Rash—Etoposide—brain cancer	0.000317	0.000755	CcSEcCtD
Maraviroc—Dermatitis—Etoposide—brain cancer	0.000317	0.000754	CcSEcCtD
Maraviroc—Headache—Etoposide—brain cancer	0.000315	0.00075	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—SUFU—brain cancer	0.000315	0.00716	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GFAP—brain cancer	0.000303	0.0069	CbGpPWpGaD
Maraviroc—Nausea—Etoposide—brain cancer	0.000299	0.000711	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—VAV1—brain cancer	0.000293	0.00667	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HEY1—brain cancer	0.000288	0.00654	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—DLL1—brain cancer	0.000282	0.00642	CbGpPWpGaD
Maraviroc—CYP3A4—endocrine gland—brain cancer	0.000271	0.0206	CbGeAlD
Maraviroc—CCR5—Disease—VAV1—brain cancer	0.000247	0.00563	CbGpPWpGaD
Maraviroc—CYP3A4—central nervous system—brain cancer	0.000244	0.0185	CbGeAlD
Maraviroc—CCR5—Signaling Pathways—SHH—brain cancer	0.00024	0.00546	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TRPC6—brain cancer	0.000231	0.00526	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SMO—brain cancer	0.000227	0.00517	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PTCH1—brain cancer	0.000227	0.00517	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000216	0.00492	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000213	0.00485	CbGpPWpGaD
Maraviroc—CCR5—Disease—HES1—brain cancer	0.000213	0.00484	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PIK3CG—brain cancer	0.000205	0.00467	CbGpPWpGaD
Maraviroc—CCR5—Disease—PDGFRA—brain cancer	0.000203	0.00461	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PIK3CG—brain cancer	0.000186	0.00424	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NOTCH2—brain cancer	0.000182	0.00414	CbGpPWpGaD
Maraviroc—CCR5—Disease—IRS2—brain cancer	0.000178	0.00405	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—VAV1—brain cancer	0.000173	0.00394	CbGpPWpGaD
Maraviroc—CCR5—Disease—APC—brain cancer	0.000157	0.00358	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HES1—brain cancer	0.000149	0.00339	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—IL2—brain cancer	0.000144	0.00328	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PDGFRA—brain cancer	0.000142	0.00323	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SPP1—brain cancer	0.000138	0.00313	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL2—brain cancer	0.000131	0.00298	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IRS2—brain cancer	0.000125	0.00283	CbGpPWpGaD
Maraviroc—CCR5—Disease—ERBB2—brain cancer	0.000122	0.00278	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PIK3CG—brain cancer	0.00011	0.0025	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—APC—brain cancer	0.00011	0.0025	CbGpPWpGaD
Maraviroc—CCR5—Disease—CTNNB1—brain cancer	0.000107	0.00243	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—EGFR—brain cancer	0.0001	0.00228	CbGpPWpGaD
Maraviroc—CCR5—Disease—STAT3—brain cancer	9.3e-05	0.00212	CbGpPWpGaD
Maraviroc—CCR5—Disease—MYC—brain cancer	8.65e-05	0.00197	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RELA—brain cancer	8.6e-05	0.00196	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ERBB2—brain cancer	8.54e-05	0.00194	CbGpPWpGaD
Maraviroc—CCR5—Disease—EGFR—brain cancer	8.46e-05	0.00192	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL2—brain cancer	7.74e-05	0.00176	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCND1—brain cancer	7.55e-05	0.00172	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CTNNB1—brain cancer	7.47e-05	0.0017	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—VEGFA—brain cancer	6.58e-05	0.0015	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—STAT3—brain cancer	6.52e-05	0.00148	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MYC—brain cancer	6.05e-05	0.00138	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—EGFR—brain cancer	5.92e-05	0.00135	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TP53—brain cancer	4.97e-05	0.00113	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP2C9—brain cancer	3.7e-05	0.000842	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—BSG—brain cancer	3.15e-05	0.000716	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—IDH1—brain cancer	2.7e-05	0.000615	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ENO2—brain cancer	2.14e-05	0.000486	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PIK3CG—brain cancer	9.81e-06	0.000223	CbGpPWpGaD
